Splice Modification to Restore Functional Dystrophin Synthesis in Duchenne Muscular Dystrophy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|8|988-1001

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.8, 2010-03, pp. : 988-1001

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adeno-Associated Virus (AAV) Mediated Dystrophin Gene Transfer Studies and Exon Skipping Strategies for Duchenne Muscular Dystrophy (DMD)

By  

Current Gene Therapy, Vol. 15, Iss. 4, 2015-01 ,pp. : 395-415

Bentham Science Publishers

Access to resources Recommend Favorite

Cell Penetrating Peptide Delivery of Splice Directing Oligonucleotides as a Treatment for Duchenne Muscular Dystrophy

By  

Current Pharmaceutical Design, Vol. 19, Iss. 16, 2013-05 ,pp. : 2948-2962

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging drugs for Duchenne muscular dystrophy

By Malik Vinod   Rodino-Klapac Louise R.   Mendell Jerry R  

Expert Opinion on Emerging Drugs, Vol. 17, Iss. 2, 2012-06 ,pp. : 261-277

Informa Healthcare

Access to resources Recommend Favorite

Pathophysiology and Therapy of Cardiac Dysfunction in Duchenne Muscular Dystrophy

By Judge Daniel P.   Kass David A.   Thompson W. Reid   Wagner Kathryn R.  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 5, 2011-10 ,pp. : 287-294

Adis International

Access to resources Recommend Favorite

Duchenne muscular dystrophy drug discovery – the application of utrophin promoter activation screening

By Moorwood Catherine   Khurana Tejvir S  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 5, 2013-06 ,pp. : 569-581

Informa Healthcare

Access to resources Recommend Favorite